HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel approach to analysis of in vitro tumor angiogenesis with a variable-pressure scanning electron microscope: suppression by matrix metalloproteinase inhibitor SI-27.

Abstract
Degradation of basement membrane by metalloproteinases (MMP) is a critical step in tumor angiogenesis. To evaluate in vitro angiogenesis, several models have been employed, including bovine cornea, fenestrated rat brain, Matrigel, and others. These models did not provide quantitative analysis of capillary formation. The current study aimed for a novel approach to in vitro assay of angiogenesis with a "wet scanning electron microscope (SEM)" to investigate suppression of tumor angiogenesis by the MMP inhibitor, SI-27. The effects of noncytotoxic concentrations of SI-27 (1-100 microM) were determined on nonmitogenic vascular endothelial growth factor (VEGF) (10 ng/ml)-mediated cell motility and in vitro angiogenesis of human umbilical vein endothelial cells (HUVECs). Activities of MMP and tissue inhibitor of metalloproteinase (TIMP) were determined by enzyme-linked immunosorbent assay (ELISA). Subsequently, the inhibitory effect of SI-27 was examined on in vitro angiogenesis stimulated by supernatants of human glioma cell lines (U87MG, U251MG, or U373MG). In vitro angiogenesis was quantitatively analyzed with a variable-pressure SEM. Cell motility and in vitro angiogenesis by HUVECs were significantly increased by VEGF along with elevated MMP-1 and -2 activity, whereas SI-27 significantly suppressed VEGF-mediated in vitro angiogenesis and inactivated both MMP-1 and MMP-2, but not inhibited cell motility. The angiogenesis promoted by glioma supernatants showed a significant reduction in the presence of SI-27. SI-27, a novel MMP inhibitor, inhibited tumor angiogenesis in vitro. It can be anticipated to prevent tumor growth through its angiosuppressive effect. Quantitative analysis with a variable-pressure SEM is a novel approach to in vitro angiogenesis assay.
AuthorsD Yoshida, M Noha, K Watanabe, Y Sugisaki, A Teramoto
JournalBrain tumor pathology (Brain Tumor Pathol) Vol. 18 Issue 2 Pg. 89-100 ( 2001) ISSN: 1433-7398 [Print] Japan
PMID11908879 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inhibitors
  • Culture Media, Conditioned
  • Matrix Metalloproteinase Inhibitors
  • Neoplasm Proteins
  • Oligopeptides
  • Protease Inhibitors
  • Recombinant Proteins
  • SI 27
  • Tissue Inhibitor of Metalloproteinases
  • Vascular Endothelial Growth Factor A
  • Matrix Metalloproteinases
Topics
  • Angiogenesis Inhibitors (pharmacology)
  • Chemotaxis (drug effects)
  • Culture Media, Conditioned (pharmacology)
  • Endothelium, Vascular (drug effects)
  • Humans
  • Matrix Metalloproteinase Inhibitors
  • Matrix Metalloproteinases (analysis, physiology)
  • Microscopy, Electron (methods)
  • Molecular Structure
  • Neoplasm Proteins (analysis, antagonists & inhibitors, physiology)
  • Neovascularization, Pathologic (pathology)
  • Oligopeptides (chemistry, pharmacology)
  • Protease Inhibitors (pharmacology)
  • Recombinant Proteins (pharmacology)
  • Tight Junctions (drug effects, ultrastructure)
  • Tissue Inhibitor of Metalloproteinases (analysis)
  • Tumor Cells, Cultured (drug effects)
  • Vascular Endothelial Growth Factor A (analysis, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: